Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.

Typeset version

 

TY  - CONF
  - P Fitzgerald, D Harris, S Crotty, A Harkin, A Mandel, AE Bolton, AM Sullivan, Y Nolan. 
  - Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.
  - 2005
  - January
  - Validated
  - 1
  - ()
DA  - 2005/01
ER  - 
@inproceedings{V19908174,
   = {P Fitzgerald,  D Harris and  S Crotty,  A Harkin and  A Mandel,  AE Bolton and  AM Sullivan,  Y Nolan.  },
   = {{Treatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.}},
   = {2005},
   = {January},
   = {Validated},
   = {1},
   = {()},
  source = {IRIS}
}
AUTHORSP Fitzgerald, D Harris, S Crotty, A Harkin, A Mandel, AE Bolton, AM Sullivan, Y Nolan.
TITLE
PUBLICATION_NAMETreatment with a novel phospholipid-based drug formulation inhibits 6-hydroxydopamine-induced p38 activation in rat substantia nigra.
YEAR2005
MONTHJanuary
STATUSValidated
PEER_REVIEW1
TIMES_CITED()
SEARCH_KEYWORD
EDITORS
START_PAGE
END_PAGE
LOCATION
START_DATE
END_DATE
ABSTRACT
FUNDED_BY
URL
DOI_LINK
FUNDING_BODY
GRANT_DETAILS